Use of rosuvastatin for the acute treatment of spontaneous intracerebral haemorrhage

Objetive: Spontaneous intracerebral haemorrhage (ICH) represents the more fatal kind of stroke, there is not available a treatment that have demonstrated an improvement of outcome. Statins are cholesterol reducers, of which in the last years an additional neuroprotector effect have been described. We performed a pilot clinical trial study in order to evaluate if the use of statins, specificaly rosuvastatin is related with better outcome. Methods: Between August and December 2006 we accomplished a prospective/retrospective non randomized clinical trial. The prospective group was treated with rosuvastatin (20mg) 1…